browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
48d02fb4-216c-4a09-bbf3-5a49815a2559
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 14:07:29
Income (reported)
$60,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

AKIN GUMP STRAUSS HAUER & FELD

Law firm

Contact
BRIAN POMPER
Phone
+1 202-887-4000
Address
zip:20006, city:WASHINGTON, state:DC, street:2001 K St NW
Client

KYVERNA THERAPEUTICS, INC.

Biopharmaceutical company focused on developing cell therapies for autoimmune diseases.

State
CA
Country
US
Effective date
2025-10-10
Issues lobbied + lobbyists (1)

HCR — Health Issues

Issues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and Multiple Sclerosis; Issues related to appropriations report language for Fiscal Year 2027.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.